Evidence map›Paper›PMID 42254666›Full record

ArticlePeerJ2026

European foulbrood disease and protein supplementation in honey bee (

Amanda S Gregoris, Alison McAfee, Heather Higo, Julia Common, Bradford Vinson, Abigail Chapman, Abdullah Ibrahim, Jeffery S Pettis, Patricia Wolf Veiga, Carlos Castillo and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amanda S GregorisBeaverlodge Research Farm, Agriculture and Agri-Food Canada, Beaverlodge, Alberta, Canada.
Alison McAfeeDepartment of Applied Ecology, North Carolina State University, Raleigh, NC, United States of America.
Heather HigoDepartment of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Julia CommonDepartment of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Bradford VinsonDepartment of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Abigail ChapmanDepartment of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Abdullah IbrahimBeaverlodge Research Farm, Agriculture and Agri-Food Canada, Beaverlodge, Alberta, Canada.
Jeffery S PettisPettis and Associates LLC., Salisbury, MD, United States of America.
Patricia Wolf VeigaNational Bee Diagnostic Centre, Northwestern Polytechnic, Beaverlodge, Alberta, Canada.
Carlos CastilloNational Bee Diagnostic Centre, Northwestern Polytechnic, Beaverlodge, Alberta, Canada.
Leonard J FosterDepartment of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Stephen F PernalBeaverlodge Research Farm, Agriculture and Agri-Food Canada, Beaverlodge, Alberta, Canada.
M Marta GuarnaBeaverlodge Research Farm, Agriculture and Agri-Food Canada, Beaverlodge, Alberta, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beekeepers engaging in highbush blueberry pollination in Canada and the U.S. have raised concerns over poor colony health outcomes presenting as European foulbrood disease (EFB), which highlights a need for improved management strategies supporting colony health during and after pollination. We assessed over 200 colonies belonging to five beekeepers before, at the end, and three weeks following the end of the blueberry pollination period. Half of the colonies at each site were provided with MegaBee pollen supplement and scored for EFB prevalence and severity to test the hypothesis that protein patty supplementation could prevent or mitigate disease development. Before pollination, EFB prevalence was overall low for each beekeeper, with 0-17% of colonies displaying symptoms. In contrast, EFB prevalence was higher post-pollination, ranging from 12-57% symptomatic colonies, though temporal changes were not statistically significant for every beekeeper. Field disease assessments were corroborated with droplet digital PCR (ddPCR) analyses of

Indexed as

Blueberry PlantsPlant DiseasesPollinationAnimalsBeekeepingBeesBritish ColumbiaEnterococcaceaePollenApis melliferaBlueberriesEuropean foulbrood diseaseHoney beesMelissococcus plutoniusNutritionPollination

Identifiers

PMID42254666
PMCPMC13242188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.